N/A
N=40
Impact of Symbiotic Administration on Intestinal Function of Head and Neck Patients Surgically Treated
Head and Neck Cancer · Synbiotics · Nutrition Therapy
Bottom Line
View on ClinicalTrials.gov: NCT02654652 ↗Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Jun 2019
Primary outcome: Primary: Serum DAO Enzyme Concentration — 3; 2.5 ng/mL
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Symbiotic (Dietary_supplement); Maltodextrin (Dietary_supplement)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Federal University of Minas Gerais
- Primary completion
- Jan 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Serum DAO Enzyme Concentration |
3; 2.5 | — |
| SECONDARY Infection Rate |
11; 7 | — |
Summary
The purpose of this study is to determine whether the symbiotic use in patients with head and neck cancer impact on intestinal function after surgical treatment.
Eligibility Criteria
Inclusion Criteria
- head and neck cancer with primary surgical treatment, enteral nutrition by enteral tube.
Exclusion Criteria
- three months antibiotic use earlier the surgery, recently radiotherapy or quimiotherapy, inflammatory bowel disease.
Data sourced from ClinicalTrials.gov (NCT02654652). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.